Mechanical prosthetic heart valves, though more durable than bioprostheses, are more
thrombogenic and require lifelong anticoagulation. Mechanical valve dysfunction can be …

All foreign bodies inserted in the circulatory system are thrombogenic and require temporary
or lifelong antithrombotic therapies to prevent thrombosis. The adequate level of …

Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

Fibrinolytic agents catalyze the conversion of the inactive proenzyme plasminogen into the
active protease plasmin, degrading fibrin within the thrombus and recanalizing occluded …

Mechanical prosthetic valve thrombosis (MPVT) is a common complication of valvular
implantations. This study compared the efficacy and safety of different treatments for MPVT …

Background Optimal first-trimester anticoagulation is still challenging in pregnant women
with mechanical heart valves (MHVs) requiring high-dose warfarin. This multicenter …

Increased inflammatory biomarkers have been reported in prosthetic heart valve thrombosis
(PHVT). Monocyte to HDL ratio (MHR) and albumin to CRP levels (CAR) are two biomarkers …

BACKGROUND: Surgery or fibrinolysis is the currently available evidence-based treatment
for obstructive mechanical valve thrombus. We reported the feasibility and short-term …

Left-sided bioprosthesis valve thrombosis (LSBVT) is a challenging complication
necessitating invasive interventions. In this study, we introduce a novel, minimally invasive …

Background Prosthetic valve thrombosis (PVT) is a severe and life-threatening complication.
Surgery and thrombolytic therapy (TT) carry a high risk, and in several circumstances …